Skip to main content
Top
Published in: Inflammation 6/2011

01-12-2011

Tumor Necrosis Factor-α Up-Regulates the Expression of β1,4-Galactosyltransferase-I in Human Fibroblast-like Synoviocytes

Authors: Dawei Xu, Zhiming Cui, Wei Liu, Ran Tao, Tao Tao, Aiguo Shen, Youhua Wang

Published in: Inflammation | Issue 6/2011

Login to get access

Abstract

β1,4-Galactosyltransferase-I (β1,4-GalT-I), which transfers galactose to the terminal N-acetylglucosamine of N- and O-linked glycans in a β1,4-linkage, is considered to be the major galactosyltransferase among the seven members of the subfamily responsible for β4 galactosylation. We previously reported, for the first time, that β1,4-GalT-I may play an important role in the inflammatory processes in synovial tissue of patients with rheumatoid arthritis (RA). In this study, we analyzed whether β1,4-GalT-I expression correlates with the expression of tumor necrosis factor-α (TNF-α) in RA. We show firstly the overexpression and co-localization of β1,4-GalT-I and TNF-α in synovial tissue of RA patients. Then, lipopolysaccharide (LPS) induces β1,4-GalT-I mRNA up-regulation in fibroblast-like synoviocytes (FLSs) through endogenous TNF-α overexpression. In addition, we observed that not only endogenous TNF-α but also exogenous TNF-α induced β1,4-GalT-I mRNA production in FLSs, and TNF-α-knockdown reverses the up-regulation of β1,4-GalT-I in FLSs induced by LPS or TNF-α. These results suggest that TNF-α contributes to the up-regulation of β1,4-GalT-I mRNA in human FLSs.
Literature
1.
go back to reference Joosten, L.A., T.R. Radstake, E. Lubberts, L.A. van den Bersselaar, P.L. van Riel, P.L. van Lent, P. Barrera, and W.B. van den Berg. 2003. Association of interleukin-18 expression with enhanced levels of both interleukin-1beta and tumor necrosis factor alpha in knee synovial tissue of patients with rheumatoid arthritis. Arthritis and Rheumatism 48: 339–347.PubMedCrossRef Joosten, L.A., T.R. Radstake, E. Lubberts, L.A. van den Bersselaar, P.L. van Riel, P.L. van Lent, P. Barrera, and W.B. van den Berg. 2003. Association of interleukin-18 expression with enhanced levels of both interleukin-1beta and tumor necrosis factor alpha in knee synovial tissue of patients with rheumatoid arthritis. Arthritis and Rheumatism 48: 339–347.PubMedCrossRef
2.
go back to reference Apweiler, R., H. Hermjakob, and N. Sharon. 1999. On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database. Biochimica et Biophysica Acta 1473: 4–8.PubMed Apweiler, R., H. Hermjakob, and N. Sharon. 1999. On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database. Biochimica et Biophysica Acta 1473: 4–8.PubMed
3.
go back to reference Furukawa, K., and T. Sato. 1999. Beta-1, 4-galactosylation of N-glycans is a complex process. Biochimica et Biophysica Acta 1473: 54–66.PubMed Furukawa, K., and T. Sato. 1999. Beta-1, 4-galactosylation of N-glycans is a complex process. Biochimica et Biophysica Acta 1473: 54–66.PubMed
4.
go back to reference Shur, B.D., S. Evans, and Q. Lu. 1998. Cell surface galactosyltransferase: current issues. Glycoconjugate Journal 15: 537–548.PubMedCrossRef Shur, B.D., S. Evans, and Q. Lu. 1998. Cell surface galactosyltransferase: current issues. Glycoconjugate Journal 15: 537–548.PubMedCrossRef
5.
go back to reference Hathaway, H.J., and B.D. Shur. 1992. Cell surface beta 1, 4-galactosyltransferase functions during neural crest cell migration and neurulation in vivo. The Journal of Cell Biology 117: 369–382.PubMedCrossRef Hathaway, H.J., and B.D. Shur. 1992. Cell surface beta 1, 4-galactosyltransferase functions during neural crest cell migration and neurulation in vivo. The Journal of Cell Biology 117: 369–382.PubMedCrossRef
6.
go back to reference Eckstein, D.J., and B.D. Shur. 1992. Cell surface beta-1, 4-galactosyltransferase is associated with the detergent-insoluble cytoskeleton on migrating mesenchymal cells. Experimental Cell Research 201: 83–90.PubMedCrossRef Eckstein, D.J., and B.D. Shur. 1992. Cell surface beta-1, 4-galactosyltransferase is associated with the detergent-insoluble cytoskeleton on migrating mesenchymal cells. Experimental Cell Research 201: 83–90.PubMedCrossRef
7.
go back to reference Miller, D.J., M.B. Macek, and B.D. Shur. 1992. Complementarity between sperm surface beta-1, 4-galactosyltransferase and egg-coat ZP3 mediates sperm–egg binding. Nature 357: 589–593.PubMedCrossRef Miller, D.J., M.B. Macek, and B.D. Shur. 1992. Complementarity between sperm surface beta-1, 4-galactosyltransferase and egg-coat ZP3 mediates sperm–egg binding. Nature 357: 589–593.PubMedCrossRef
8.
go back to reference Evans, S.C., L.C. Lopez, and B.D. Shur. 1993. Dominant negative mutation in cell surface beta 1, 4-galactosyltransferase inhibits cell–cell and cell–matrix interactions. The Journal of Cell Biology 120: 1045–1057.PubMedCrossRef Evans, S.C., L.C. Lopez, and B.D. Shur. 1993. Dominant negative mutation in cell surface beta 1, 4-galactosyltransferase inhibits cell–cell and cell–matrix interactions. The Journal of Cell Biology 120: 1045–1057.PubMedCrossRef
9.
go back to reference Huang, Q., B.D. Shur, and P.C. Begovac. 1995. Overexpressing cell surface beta 1.4-galactosyltransferase in PC12 cells increases neurite outgrowth on laminin. Journal of Cell Science 108(Pt 2): 839–847.PubMed Huang, Q., B.D. Shur, and P.C. Begovac. 1995. Overexpressing cell surface beta 1.4-galactosyltransferase in PC12 cells increases neurite outgrowth on laminin. Journal of Cell Science 108(Pt 2): 839–847.PubMed
10.
go back to reference Maillet, C.M., and B.D. Shur. 1994. Perturbing cell surface beta-(1, 4)-galactosyltransferase on F9 embryonal carcinoma cells arrests cell growth and induces laminin synthesis. Journal of Cell Science 107(Pt 6): 1713–1724.PubMed Maillet, C.M., and B.D. Shur. 1994. Perturbing cell surface beta-(1, 4)-galactosyltransferase on F9 embryonal carcinoma cells arrests cell growth and induces laminin synthesis. Journal of Cell Science 107(Pt 6): 1713–1724.PubMed
11.
go back to reference Asano, M., S. Nakae, N. Kotani, N. Shirafuji, A. Nambu, N. Hashimoto, H. Kawashima, M. Hirose, M. Miyasaka, S. Takasaki, and Y. Iwakura. 2003. Impaired selectin–ligand biosynthesis and reduced inflammatory responses in beta-1, 4-galactosyltransferase-I-deficient mice. Blood 102: 1678–1685.PubMedCrossRef Asano, M., S. Nakae, N. Kotani, N. Shirafuji, A. Nambu, N. Hashimoto, H. Kawashima, M. Hirose, M. Miyasaka, S. Takasaki, and Y. Iwakura. 2003. Impaired selectin–ligand biosynthesis and reduced inflammatory responses in beta-1, 4-galactosyltransferase-I-deficient mice. Blood 102: 1678–1685.PubMedCrossRef
12.
go back to reference Mori, R., T. Kondo, T. Nishie, T. Ohshima, and M. Asano. 2004. Impairment of skin wound healing in beta-1, 4-galactosyltransferase-deficient mice with reduced leukocyte recruitment. The American Journal of Pathology 164: 1303–1314.PubMedCrossRef Mori, R., T. Kondo, T. Nishie, T. Ohshima, and M. Asano. 2004. Impairment of skin wound healing in beta-1, 4-galactosyltransferase-deficient mice with reduced leukocyte recruitment. The American Journal of Pathology 164: 1303–1314.PubMedCrossRef
13.
go back to reference Arend, W.P., and J.M. Dayer. 1995. Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis. Arthritis and Rheumatism 38: 151–160.PubMedCrossRef Arend, W.P., and J.M. Dayer. 1995. Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis. Arthritis and Rheumatism 38: 151–160.PubMedCrossRef
14.
go back to reference Feldmann, M., F.M. Brennan, and R.N. Maini. 1996. Role of cytokines in rheumatoid arthritis. Annual Review of Immunology 14: 397–440.PubMedCrossRef Feldmann, M., F.M. Brennan, and R.N. Maini. 1996. Role of cytokines in rheumatoid arthritis. Annual Review of Immunology 14: 397–440.PubMedCrossRef
15.
go back to reference Collins, T., M.A. Read, A.S. Neish, M.Z. Whitley, D. Thanos, and T. Maniatis. 1995. Transcriptional regulation of endothelial cell adhesion molecules: NF-kappa B and cytokine-inducible enhancers. The FASEB Journal 9: 899–909.PubMed Collins, T., M.A. Read, A.S. Neish, M.Z. Whitley, D. Thanos, and T. Maniatis. 1995. Transcriptional regulation of endothelial cell adhesion molecules: NF-kappa B and cytokine-inducible enhancers. The FASEB Journal 9: 899–909.PubMed
16.
go back to reference Lowe, J.B. 2003. Glycan-dependent leukocyte adhesion and recruitment in inflammation. Current Opinion in Cell Biology 15: 531–538.PubMedCrossRef Lowe, J.B. 2003. Glycan-dependent leukocyte adhesion and recruitment in inflammation. Current Opinion in Cell Biology 15: 531–538.PubMedCrossRef
17.
go back to reference Wang, Y., D. Xu, R. Tao, H. Wang, Q. Wang, and A. Shen. 2010. beta1,4-Galactosyltransferase-I contributes to the inflammatory processes in synovial tissue of patients with rheumatoid arthritis. Inflammation Research. doi:10.1007/s00011-010-0217-1 Wang, Y., D. Xu, R. Tao, H. Wang, Q. Wang, and A. Shen. 2010. beta1,4-Galactosyltransferase-I contributes to the inflammatory processes in synovial tissue of patients with rheumatoid arthritis. Inflammation Research. doi:10.​1007/​s00011-010-0217-1
18.
go back to reference Arnett, F.C., S.M. Edworthy, D.A. Bloch, D.J. Mcshane, J.F. Fries, N.S. Cooper, L.A. Healey, S.R. Kaplan, M.H. Liang, H.S. Luthra, and A. Et. 1988. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis and Rheumatism 31: 315–324.PubMedCrossRef Arnett, F.C., S.M. Edworthy, D.A. Bloch, D.J. Mcshane, J.F. Fries, N.S. Cooper, L.A. Healey, S.R. Kaplan, M.H. Liang, H.S. Luthra, and A. Et. 1988. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis and Rheumatism 31: 315–324.PubMedCrossRef
19.
go back to reference Prevoo, M.L., M.A. van’t Hof, H.H. Kuper, M.A. van Leeuwen, L.B. van de Putte, and P.L. van Riel. 1995. Modified disease activity scores that include 28-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis and Rheumatism 38: 44–48.PubMedCrossRef Prevoo, M.L., M.A. van’t Hof, H.H. Kuper, M.A. van Leeuwen, L.B. van de Putte, and P.L. van Riel. 1995. Modified disease activity scores that include 28-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis and Rheumatism 38: 44–48.PubMedCrossRef
20.
go back to reference Radstake, T.R., M.F. Roelofs, Y.M. Jenniskens, B. Oppers-Walgreen, P.L. van Riel, P. Barrera, L.A. Joosten, and W.B. van den Berg. 2004. Expression of toll-like receptors 2 and 4 in rheumatoid synovial tissue and regulation by proinflammatory cytokines interleukin-12 and interleukin-18 via interferon-gamma. Arthritis and Rheumatism 50: 3856–3865.PubMedCrossRef Radstake, T.R., M.F. Roelofs, Y.M. Jenniskens, B. Oppers-Walgreen, P.L. van Riel, P. Barrera, L.A. Joosten, and W.B. van den Berg. 2004. Expression of toll-like receptors 2 and 4 in rheumatoid synovial tissue and regulation by proinflammatory cytokines interleukin-12 and interleukin-18 via interferon-gamma. Arthritis and Rheumatism 50: 3856–3865.PubMedCrossRef
21.
go back to reference Vervoordeldonk, M.J., and P.P. Tak. 2002. Cytokines in rheumatoid arthritis. Current Rheumatology Reports 4: 208–217.PubMedCrossRef Vervoordeldonk, M.J., and P.P. Tak. 2002. Cytokines in rheumatoid arthritis. Current Rheumatology Reports 4: 208–217.PubMedCrossRef
22.
go back to reference Kamijo, S., A. Nakajima, K. Kamata, H. Kurosawa, H. Yagita, and K. Okumura. 2008. Involvement of TWEAK/Fn14 interaction in the synovial inflammation of RA. Rheumatology (Oxford) 47: 442–450.CrossRef Kamijo, S., A. Nakajima, K. Kamata, H. Kurosawa, H. Yagita, and K. Okumura. 2008. Involvement of TWEAK/Fn14 interaction in the synovial inflammation of RA. Rheumatology (Oxford) 47: 442–450.CrossRef
23.
go back to reference Bartok, B., and G.S. Firestein. 2010. Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis. Immunological Reviews 233: 233–255.PubMedCrossRef Bartok, B., and G.S. Firestein. 2010. Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis. Immunological Reviews 233: 233–255.PubMedCrossRef
24.
go back to reference Take, Y., K. Nakata, J. Hashimoto, H. Tsuboi, N. Nishimoto, T. Ochi, and H. Yoshikawa. 2009. Specifically modified osteopontin in rheumatoid arthritis fibroblast-like synoviocytes supports interaction with B cells and enhances production of interleukin-6. Arthritis and Rheumatism 60: 3591–3601.PubMedCrossRef Take, Y., K. Nakata, J. Hashimoto, H. Tsuboi, N. Nishimoto, T. Ochi, and H. Yoshikawa. 2009. Specifically modified osteopontin in rheumatoid arthritis fibroblast-like synoviocytes supports interaction with B cells and enhances production of interleukin-6. Arthritis and Rheumatism 60: 3591–3601.PubMedCrossRef
25.
go back to reference Settles, B., A. Stevenson, K. Wilson, C. Mack, T. Ezell, M.F. Davis, and L.D. Taylor. 2001. Down-regulation of cell adhesion molecules LFA-1 and ICAM-1 after in vitro treatment with the anti-TNF-alpha agent thalidomide. Cell Molecular Biology (Noisy-le-grand) 47: 1105–1114. Settles, B., A. Stevenson, K. Wilson, C. Mack, T. Ezell, M.F. Davis, and L.D. Taylor. 2001. Down-regulation of cell adhesion molecules LFA-1 and ICAM-1 after in vitro treatment with the anti-TNF-alpha agent thalidomide. Cell Molecular Biology (Noisy-le-grand) 47: 1105–1114.
26.
go back to reference Gonzalez-Gay, M.A., M.T. Garcia-Unzueta, J.M. De Matias, C. Gonzalez-Juanatey, C. Garcia-Porrua, A. Sanchez-Andrade, J. Martin, and J. Llorca. 2006. Influence of anti-TNF-alpha infliximab therapy on adhesion molecules associated with atherogenesis in patients with rheumatoid arthritis. Clinical and Experimental Rheumatology 24: 373–379.PubMed Gonzalez-Gay, M.A., M.T. Garcia-Unzueta, J.M. De Matias, C. Gonzalez-Juanatey, C. Garcia-Porrua, A. Sanchez-Andrade, J. Martin, and J. Llorca. 2006. Influence of anti-TNF-alpha infliximab therapy on adhesion molecules associated with atherogenesis in patients with rheumatoid arthritis. Clinical and Experimental Rheumatology 24: 373–379.PubMed
27.
go back to reference Lowe, J.B. 1997. Selectin ligands, leukocyte trafficking, and fucosyltransferase genes. Kidney International 51: 1418–1426.PubMedCrossRef Lowe, J.B. 1997. Selectin ligands, leukocyte trafficking, and fucosyltransferase genes. Kidney International 51: 1418–1426.PubMedCrossRef
28.
go back to reference McEver, R.P., K.L. Moore, and R.D. Cummings. 1995. Leukocyte trafficking mediated by selectin–carbohydrate interactions. The Journal of Biological Chemistry 270: 11025–11028.PubMedCrossRef McEver, R.P., K.L. Moore, and R.D. Cummings. 1995. Leukocyte trafficking mediated by selectin–carbohydrate interactions. The Journal of Biological Chemistry 270: 11025–11028.PubMedCrossRef
29.
go back to reference Hiraoka, N., B. Petryniak, J. Nakayama, S. Tsuboi, M. Suzuki, J.C. Yeh, D. Izawa, T. Tanaka, M. Miyasaka, J.B. Lowe, and M. Fukuda. 1999. A novel, high endothelial venule-specific sulfotransferase expresses 6-sulfo sialyl Lewis(x), an L-selectin ligand displayed by CD34. Immunity 11: 79–89.PubMedCrossRef Hiraoka, N., B. Petryniak, J. Nakayama, S. Tsuboi, M. Suzuki, J.C. Yeh, D. Izawa, T. Tanaka, M. Miyasaka, J.B. Lowe, and M. Fukuda. 1999. A novel, high endothelial venule-specific sulfotransferase expresses 6-sulfo sialyl Lewis(x), an L-selectin ligand displayed by CD34. Immunity 11: 79–89.PubMedCrossRef
30.
go back to reference Maemura, K., and M. Fukuda. 1992. Poly-N-acetyllactosaminyl O-glycans attached to leukosialin. The presence of sialyl Le(x) structures in O-glycans. The Journal of Biological Chemistry 267: 24379–24386.PubMed Maemura, K., and M. Fukuda. 1992. Poly-N-acetyllactosaminyl O-glycans attached to leukosialin. The presence of sialyl Le(x) structures in O-glycans. The Journal of Biological Chemistry 267: 24379–24386.PubMed
31.
go back to reference Wilkins, P.P., R.P. McEver, and R.D. Cummings. 1996. Structures of the O-glycans on P-selectin glycoprotein ligand-1 from HL-60 cells. The Journal of Biological Chemistry 271: 18732–18742.PubMedCrossRef Wilkins, P.P., R.P. McEver, and R.D. Cummings. 1996. Structures of the O-glycans on P-selectin glycoprotein ligand-1 from HL-60 cells. The Journal of Biological Chemistry 271: 18732–18742.PubMedCrossRef
32.
go back to reference Kotani, N., M. Asano, Y. Iwakura, and S. Takasaki. 2001. Knockout of mouse beta 1, 4-galactosyltransferase-1 gene results in a dramatic shift of outer chain moieties of N-glycans from type 2 to type 1 chains in hepatic membrane and plasma glycoproteins. The Biochemical Journal 357: 827–834.PubMedCrossRef Kotani, N., M. Asano, Y. Iwakura, and S. Takasaki. 2001. Knockout of mouse beta 1, 4-galactosyltransferase-1 gene results in a dramatic shift of outer chain moieties of N-glycans from type 2 to type 1 chains in hepatic membrane and plasma glycoproteins. The Biochemical Journal 357: 827–834.PubMedCrossRef
33.
go back to reference Garcia-Vallejo, J.J., W. van Dijk, I. van Die, and S.I. Gringhuis. 2005. Tumor necrosis factor-alpha up-regulates the expression of beta1, 4-galactosyltransferase I in primary human endothelial cells by mRNA stabilization. The Journal of Biological Chemistry 280: 12676–12682.PubMedCrossRef Garcia-Vallejo, J.J., W. van Dijk, I. van Die, and S.I. Gringhuis. 2005. Tumor necrosis factor-alpha up-regulates the expression of beta1, 4-galactosyltransferase I in primary human endothelial cells by mRNA stabilization. The Journal of Biological Chemistry 280: 12676–12682.PubMedCrossRef
34.
go back to reference Yan, M., C. Xia, S. Niu, X. Shao, C. Cheng, J. Zhao, and A. Shen. 2007. The role of TNF-alpha and its receptors in the production of beta-1, 4 galactosyltransferase I and V mRNAs by rat primary astrocytes. Journal of Molecular Neuroscience 33: 155–162.PubMedCrossRef Yan, M., C. Xia, S. Niu, X. Shao, C. Cheng, J. Zhao, and A. Shen. 2007. The role of TNF-alpha and its receptors in the production of beta-1, 4 galactosyltransferase I and V mRNAs by rat primary astrocytes. Journal of Molecular Neuroscience 33: 155–162.PubMedCrossRef
Metadata
Title
Tumor Necrosis Factor-α Up-Regulates the Expression of β1,4-Galactosyltransferase-I in Human Fibroblast-like Synoviocytes
Authors
Dawei Xu
Zhiming Cui
Wei Liu
Ran Tao
Tao Tao
Aiguo Shen
Youhua Wang
Publication date
01-12-2011
Publisher
Springer US
Published in
Inflammation / Issue 6/2011
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-010-9260-x

Other articles of this Issue 6/2011

Inflammation 6/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.